Axial Biotech develops and commercializes genetic tests and treatment solutions for spinal disorders.
Axial Biotech is a privately held, venture-backed company founded in 2002 by a group of internationally recognized spine surgeons and geneticists. Axial Biotech is focused on developing and commercializing genetic tests and treatment solutions for spinal disorders.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 27, 2007 | Series B | $15.30M | 1 | — | — | Detail |
Mar 1, 2005 | Series A | $4.10M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Ohio Biotech Group | — | Series B |
Medtronic | — | Series A |